These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
203 related items for PubMed ID: 3493088
1. Quantification of myocardial injury produced by temporary coronary artery occlusion and reflow with technetium-99m-pyrophosphate. Jansen DE, Corbett JR, Buja LM, Hansen C, Ugolini V, Parkey RW, Willerson JT. Circulation; 1987 Mar; 75(3):611-7. PubMed ID: 3493088 [Abstract] [Full Text] [Related]
2. Technetium-99m(Sn2+)pyrophosphate in ischemic and infarcted dog myocardium in early stages of acute coronary occlusion: histochemical and tissue-counting comparisons. Bianco JA, Kemper AJ, Taylor A, Lazewatsky J, Tow DE, Khuri SF. J Nucl Med; 1983 Jun; 24(6):485-91. PubMed ID: 6854398 [Abstract] [Full Text] [Related]
3. [Evaluation of coronary reperfusion for acute myocardial infarction by emission CT using technetium-99m pyrophosphate]. Hashimoto T, Kambara H, Nohara R, Fudo T, Uozu K, Tamaki S, Kawai C. J Cardiol; 1987 Jun; 17(2):231-9. PubMed ID: 2966242 [Abstract] [Full Text] [Related]
4. Effect of coronary blood flow and site of injection on Tc-99m PPi detection of early canine myocardial infarcts. Parkey RW, Kulkarni PV, Lewis SE, Datz FL, Dehmer GJ, Gutekunst DP, Buja LM, Bonte FJ, Willerson JT. J Nucl Med; 1981 Feb; 22(2):133-7. PubMed ID: 7463157 [Abstract] [Full Text] [Related]
5. Early positive technetium-99m stannous pyrophosphate images as a marker of reperfusion after thrombolytic therapy for acute myocardial infarction. Wheelan K, Wolfe C, Corbett J, Rude RE, Winniford M, Parkey RW, Buja LM, Willerson JT. Am J Cardiol; 1985 Aug 01; 56(4):252-6. PubMed ID: 4025161 [Abstract] [Full Text] [Related]
6. A comparison of infarct identification with technetium-99m pyrophosphate and staining with triphenyl tetrazolium chloride. Izquierdo C, Devous MD, Nicod P, Buja LM, Parkey RW, Bonte FJ, Willerson JT, Lewis SE. J Nucl Med; 1983 Jun 01; 24(6):492-7. PubMed ID: 6304264 [Abstract] [Full Text] [Related]
7. Time course of technetium-99m sestamibi myocardial distribution in dogs with a permanent or transient coronary occlusion. Merhi Y, Arsenault A, Latour JG. Eur J Nucl Med; 1994 Jun 01; 21(6):481-7. PubMed ID: 8082660 [Abstract] [Full Text] [Related]
8. Relationship between Tl-201, Tc-99m (Sn) pyrophosphate and F-18 2-deoxyglucose uptake in ischemically injured dog myocardium. Sochor H, Schwaiger M, Schelbert HR, Huang SC, Ellison D, Hansen H, Selin C, Parodi O, Phelps ME. Am Heart J; 1987 Nov 01; 114(5):1066-77. PubMed ID: 3673874 [Abstract] [Full Text] [Related]
10. 99mTc-sestamibi uptake and retention during myocardial ischemia and reperfusion. Beller GA, Glover DK, Edwards NC, Ruiz M, Simanis JP, Watson DD. Circulation; 1993 Jun 01; 87(6):2033-42. PubMed ID: 8504518 [Abstract] [Full Text] [Related]
11. Progressive failure of coronary flow during reperfusion of myocardial infarction: documentation of the no reflow phenomenon with positron emission tomography. Jeremy RW, Links JM, Becker LC. J Am Coll Cardiol; 1990 Sep 01; 16(3):695-704. PubMed ID: 2387943 [Abstract] [Full Text] [Related]
12. Comparison of technetium-99m pyrophosphate and technetium-99m methylene diphosphonate with variable amounts of stannous chloride in the detection of acute myocardial infarction. Huckell VF, Lyster DM, Morrison RT, Cooper JA. Clin Nucl Med; 1985 Jul 01; 10(7):455-62. PubMed ID: 4028596 [Abstract] [Full Text] [Related]
13. Measurement of infarct size in acute canine myocardial infarction by single-photon emission computed tomography with technetium-99m pyrophosphate. Lewis SE, Devous MD, Corbett JR, Izquierdo C, Nicod P, Wolfe CL, Parkey RW, Buja LM, Willerson JT. Am J Cardiol; 1984 Jul 01; 54(1):193-9. PubMed ID: 6331146 [Abstract] [Full Text] [Related]
14. Technetium-99m-pyrophosphate uptake as an indicator of myocardial injury without infarct. Okuda K, Nohara R, Fujita M, Tamaki N, Konishi J, Sasayama S. J Nucl Med; 1994 Aug 01; 35(8):1366-70. PubMed ID: 8046495 [Abstract] [Full Text] [Related]
15. Quantification of myocardial infarction: a comparison of single photon-emission computed tomography with pyrophosphate to serial plasma MB-creatine kinase measurements. Jansen DE, Corbett JR, Wolfe CL, Lewis SE, Gabliani G, Filipchuk N, Redish G, Parkey RW, Buja LM, Jaffe AS. Circulation; 1985 Aug 01; 72(2):327-33. PubMed ID: 2988821 [Abstract] [Full Text] [Related]
16. Early detection of infarct in reperfused canine myocardium using 99mTc-glucarate. Okada DR, Johnson G, Liu Z, Hocherman SD, Khaw BA, Okada RD. J Nucl Med; 2004 Apr 01; 45(4):655-64. PubMed ID: 15073263 [Abstract] [Full Text] [Related]
17. Quantification of area at risk during coronary occlusion and degree of myocardial salvage after reperfusion with technetium-99m methoxyisobutyl isonitrile. Sinusas AJ, Trautman KA, Bergin JD, Watson DD, Ruiz M, Smith WH, Beller GA. Circulation; 1990 Oct 01; 82(4):1424-37. PubMed ID: 2401074 [Abstract] [Full Text] [Related]
18. Comparison of indium-111 antimyosin antibody and technetium-99m pyrophosphate localization in reperfused and nonreperfused myocardial infarction. Takeda K, LaFrance ND, Weisman HF, Wagner HN, Becker LC. J Am Coll Cardiol; 1991 Feb 01; 17(2):519-26. PubMed ID: 1846888 [Abstract] [Full Text] [Related]
19. Myocardial thallium-201 kinetics during coronary occlusion and reperfusion: influence of method of reflow and timing of thallium-201 administration. Granato JE, Watson DD, Flanagan TL, Gascho JA, Beller GA. Circulation; 1986 Jan 01; 73(1):150-60. PubMed ID: 3940665 [Abstract] [Full Text] [Related]
20. The effect of collateral flow and myocardial viability on the distribution of technetium-99m sestamibi in a closed-chest model of coronary occlusion and reperfusion. Chareonthaitawee P, O'Connor MK, Gibbons RJ, Ritman EL, Christian TF. Eur J Nucl Med; 2000 May 01; 27(5):508-16. PubMed ID: 10853805 [Abstract] [Full Text] [Related] Page: [Next] [New Search]